Unresectable Locally Recurrent Breast Cancer
1 clinical trials · Condition
◉ Watch Unresectable Locally Recurrent Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer (NCT07497386) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-28 |
Track Unresectable Locally Recurrent Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.